New York State Common Retirement Fund
MTNB icon

New York State Common Retirement Fund’s Matinas BioPharma MTNB Stock Holding History

New York State Common Retirement Fund’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,122
Closed -$43K – 3196
2018
Q1 		$43K Hold
1,122
– – ﹤0.01% 3037
2017
Q4 		$65K Hold
1,122
– – ﹤0.01% 3030
2017
Q3 		$74K Hold
1,122
– – ﹤0.01% 3038
2017
Q2 		$95K Buy
+1,122
New +$151K ﹤0.01% 3097

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

New York State Common Retirement Fund's MTNB Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Matinas BioPharma (MTNB) in Q2 2018, closing a stake of 1,122 shares — an estimated $43K sold.

New York State Common Retirement Fund first reported a position in MTNB in Q2 2017 and held it in 4 quarters. The position peaked at $95K in Q2 2017. 39 funds tracked by Wall St. Rank hold MTNB as of Q2 2018.

  • New York State Common Retirement Fund reported no remaining Matinas BioPharma position as of Q2 2018 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,122 Matinas BioPharma shares in Q2 2018, an estimated $43K.
  • New York State Common Retirement Fund first reported a position in Matinas BioPharma in Q2 2017 and held it in 4 quarters.
  • New York State Common Retirement Fund's Matinas BioPharma position peaked at $95K in Q2 2017.
  • 39 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.